Novo Nordisk (NYSE: NVO) reported Q1 EPS of DKK6.63, DKK0.33 worse than the analyst estimate of DKK6.96. Revenue for the quarter came in at DKK96.82 billion.

For earnings history and earnings-related data on Novo Nordisk (NVO) click here.